Abstract
Extracorporeal Removal of Low Density Lipoproteins Cholesterol and Middle Molecules from Plasma at Metabolic Syndrome, Possibilities of Cellulose Derivates
Highlights
Among US adults aged 18 years or older, the prevalence of metabolic syndrome (MetS) rose by more than 35% from 1988-1994 to 2007-2012, increasing from 25.3% to 34.2% [1]
People with the MetS are at increased risk of a cardiovascular disease, such as coronary heart disease or other diseases related to plaque buildups in artery walls and/or type II diabetes mellitus that characterizes by insulin resistance and impaired insulin secretion [5]
Increased concentrations of cholesterol of atherogenic apolipo protein B100-containing low density lipoproteins (LDL), high level of C-reactive protein and proinflammatory cytokines, protrombotic state at the patients with MetS escalates the risk of cardiovascular diseases [7]
Summary
Among US adults aged 18 years or older, the prevalence of metabolic syndrome (MetS) rose by more than 35% from 1988-1994 to 2007-2012, increasing from 25.3% to 34.2% [1]. Extracorporeal Removal of Low Density Lipoproteins Cholesterol and Middle Molecules from Plasma at Metabolic Syndrome, Possibilities of Cellulose Derivates
Sign-in/Register to view highlights & summary 
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Cardiology & Cardiovascular Therapy
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
